GRP
PDLI

Global Retirement Partners’s PDL BioPharma, Inc. PDLI Stock Holding History

Global Retirement Partners’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-400
Closed -$1K – 1847
2020
Q3 		$1K Buy
+400
New +$1.28K ﹤0.01% 1612
2020
Q2 		– Sell
-150
Closed – – 1796
2020
Q1 		$0 Hold
150
– – ﹤0.01% 1753
2019
Q4 		$0 Hold
150
– – ﹤0.01% 1761
2019
Q3 		$0 Hold
150
– – ﹤0.01% 1747
2019
Q2 		$0 Hold
150
– – ﹤0.01% 1769
2019
Q1 		$1K Hold
150
– – ﹤0.01% 1508
2018
Q4 		$0 Hold
150
– – ﹤0.01% 1630
2018
Q3 		$0 Hold
150
– – ﹤0.01% 1611
2018
Q2 		$0 Buy
+150
New +$419 ﹤0.01% 1612

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Global Retirement Partners's PDLI Position: Q4 2020 in Review

Global Retirement Partners sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 400 shares — an estimated $1K sold.

Global Retirement Partners first reported a position in PDLI in Q2 2018 and held it in 9 quarters. The position peaked at $1K in Q3 2020. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Global Retirement Partners reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Global Retirement Partners sold 400 PDL BioPharma, Inc. shares in Q4 2020, an estimated $1K.
  • Global Retirement Partners first reported a position in PDL BioPharma, Inc. in Q2 2018 and held it in 9 quarters.
  • Global Retirement Partners's PDL BioPharma, Inc. position peaked at $1K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Global Retirement Partners's 13F filing for Q4 2020, filed 13 Jan 2021.